UC Davis Health Ramps Up Project Lightspeed: Serves as Trial Site for Phase 2/3 BNT162 COVID-19 Vaccine Study
UC Davis Health was one of about 120 trial sites selected worldwide to participate in the Phase 2/3 stage testing […]
UC Davis Selected to Participate in the REGN-COV2 Clinical Trial Investigating Monoclonal Antibody Targeting COVID-19
UC Davis Health investigators, thanks to a recent federal grant, are preparing to test a promising new antibody cocktail, known […]
UC Davis Researchers benefit from Recent COVID-19 Grants
UC Davis researchers have a role in eight of the 25 COVID-19-related projects that recently received seed grants from CITRIS […]
Will Clinical Research Grow in California’s Capital?
Just as the death toll from COVID-19 rose over 90,000 in the United States, Operation Warp Speed was announced by […]
UC Davis Spinoff with Novel Antigen Specific Therapy Targeting Autoimmune Diseases Seeks Investors
A University of California, Davis (UCD) spinoff is developing a new therapeutic approach to treat autoimmune diseases. UCD researchers and […]
UC Davis Invests $4M to Launch New Research Centers: IMPACT
UC Davis will infuse $4 million over the next three years to launch four new research centers that align the […]
UC Davis Joins U.S. POINTER Study: Does Healthy Lifestyle Reduce Alzheimer’s Risk?
The Alzheimer’s Association gave $6 million to the University of California, Davis, to fund its participation in the U.S. POINTER […]
UC Davis IP Spins Out into Venture & Secures $5 Million
UC Davis, CA-based venture targeting chronic pain receives a $5 million investment from Open Philanthropy. The goal is to move […]
Record Number of UC Davis Spinoffs During Fiscal 2018 Year
Lisa Howard writing for University of California Davis reports a record number of new ventures during the fiscal 2018 year. […]
UC Davis Study Pages Helps Volunteer Patients Find Clinical Trials
Study Pages was developed by UC Davis. UC Davis Health’s mission is to discovery and share knowledge to advance health. […]
